A61K 51/1066
The tumor cell being from skin
Official title: {the tumor cell being from skin}
A61K51/1066 (The tumor cell being from skin) appears on 29 US grants and 30 published applications in this corpus.
Search patents in A61K- Granted patents
- 29
- Published applications
- 30
- Assignees
- 25
- Inventors
- 85
- Latest grant
- 16 Aug 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 2 |
| 2006 | 2 | 2 |
| 2007 | 0 | 2 |
| 2008 | 1 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 2 |
| 2011 | 0 | 0 |
| 2012 | 2 | 4 |
| 2013 | 1 | 0 |
| 2014 | 0 | 4 |
| 2015 | 2 | 1 |
| 2016 | 0 | 2 |
| 2017 | 4 | 3 |
| 2018 | 1 | 1 |
| 2019 | 2 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 1 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- N-acetylgalactosamino dendron-clearing agent for dota-pretargeted radioimmunotherapy16 Aug 2022US 11,413,354 B2Memorial Sloan Kettering Cancer Center
- Radiolabeled drug30 Mar 2021US 10,960,089 B2National University Corporation Chiba University
- Antibodies to GRP7816 Apr 2019US 10,259,884 B2Vanderbilt University
- Antibody fragments for detecting cancer and methods of use1 Jan 2019US 10,166,304 B2Regents of the University of Minnesota
- Uses of monoclonal antibody 8H910 Apr 2018US 9,938,351 B2Sloan-Kettering Institute for Cancer Research
- Radiolabeled fibronectin based scaffolds and antibodies and theranostic uses thereof22 Aug 2024US 2024/0277878 A1Bristol-Myers Squibb Company
- N-acetylgalactosamino dendron-clearing agent for dota-pretargeted radioimmunotherapy28 Oct 2021US 2021/0330805 A1Memorial Sloan Kettering Cancer Center
- Radiolabeled drug28 Mar 2019US 2019/0091353 A1National University Corporation Chiba University
- Uses of monoclonal antibody 8h926 Jul 2018US 2018/0208673 A1Sloan-Kettering Institute for Cancer Research
- Antibodies to tip-1 and grp7819 Oct 2017US 2017/0298142 A1Washington University
Most cited
By later US patents
- Chelating compounds for metal-radionuclide labeled proteins89US 4,965,392 ANeoRx Corporation · 1990
- Monoclonal antibodies against melanoma-associated antigens and hybrid cell lines producing these antibodies55US 4,849,509 AThe Wistar Institute · 1989
- Method of treating brain tumors expressing tenascin50US 5,624,659 ADuke University · 1997
- Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor48US 5,688,657 AInternational Bio-Immune Systems, Inc. · 1997
- Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy39US 5,091,514 ANeoRx Corporation · 1992